the compounds described have been shown to be potent beta-adrenergic antagonists by virtue of their ability to inhibit beta-adrenergic stimulation of adenylate cyclase or to compete for the binding of another beta-adrenergic ligand , [ 125i ] cyanopindolol , to the beta-adrenergic receptors of frog erythrocytes .
C1517880
binding
C0034785
beta-adrenergic receptors